Systems therapies for metastatic NSCLC in poor general health

Non-small cell lung cancer (NSCLC) is the cancer with the highest mortality worldwide, with two-thirds of cases detected only at locally advanced or metastatic stages. Unfortunately, recommendations for patients with reduced general health are usually not evidence-based. In this vulnerable patient group, treatment decisions should be made individually based on performance status and tumor characteristics.